Icahn gives up seat on Illumina board, backing away from challenge to diagnostics company

2024-04-05

高管变更

After upending Illumina’s leadership, activist investor Carl Icahn appears to be backing off. According to a proxy filing Thursday, Icahn’s director on Illumina’s board won’t stand for re-election, and Icahn hasn’t nominated a new ally to replace him, or others. While there’s no indication that Icahn has sold the stake he bought in the genetic sequencing company, giving up the director seat — occupied by Andrew Teno, now the CEO of Icahn Enterprises — marks a notable retreat after a protracted and often vicious proxy battle that last year led to the exit of Illumina’s CEO .

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构